Ads
related to: melasma causes in males symptoms skin problems early signs of cancer in lungs- Common Side Effects
See Possible Side Effects For A
Therapy For Metastatic Solid Tumors
- Data & Results
Explore Data To See If A
Therapy May Be An Option For You.
- Patient & Caregiver Site
Treatment For Certain People
With Metastatic Solid Tumors.
- Read About Biomarkers
What Should You Know About
IHC? Visit Site For Testing Info.
- Common Side Effects
musely.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
In short, melasma is a chronic skin condition that appears as darkened areas on the face due to an overproduction of melanin, says Gina Charles, MO, a family physician specializing in skincare. It ...
Melasma (also known as chloasma faciei, [1]: 854 or the mask of pregnancy [2] when present in pregnant women) is a tan or dark skin discoloration. Melasma is thought to be caused by sun exposure, genetic predisposition, hormone changes, and skin irritation. [ 3 ]
What Causes Melasma? The exact cause of melasma is unknown, says Dr. Robert Finney, MD, a board-certified dermatologist in New York City. But it’s believed to result from the skin’s pigment ...
If you didn’t know what melasma was last year, there’s a chance that you’ve seen its telltale signs of patchy facial discoloration in 2020. “Wearing a mask traps accumulated heat against ...
Acral lentiginous melanoma (ALM) is a type of skin cancer. [6] It typically begins as a uniform brownish mark before becoming darker and wider with a blurred, irregular border. ALM is most frequently seen on the foot of a person with darker skin but can also be found in non-sun exposed areas such as the palms, soles, and under finger and ...
Squamous-cell lung carcinoma is one of the tumor types with the highest number of mutations since smoking, the main driver of the disease, is a strong mutagenic factor. [ 5 ] Inactivating mutations in lung SCC affect many tumor suppressor genes such as TP53 (mutated in 81% of cases), MLL2 (20%), CDKN2A (15%), KEAP1 (12%) and PTEN (8%).